Prevalence of Barrett's esophagus in patients with moderate to severe erosive esophagitis

Nooman Gilani, Richard D. Gerkin, Francisco C Ramirez, Shahina Hakim, Adam C. Randolph

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Aim: To investigate the proportion of patients with moderate-severe erosive esophagitis (EE) who will have Barrett's esophagus (BE) after healing of inflammation. Methods: Patients with EE of Los Angeles (LA) class B, C and D who underwent follow-up endoscopy documenting complete mucosal healing. Results: A total of 86/169 patients were suspected of having BE (38 before healing and 48 after healing of EE) and, 46/86 eventually had the histological confirmation. At index esophago-gastro-duodenoscopy (EGD), BE was suspected in 38/169 (22%), and ultimately, histologically confirmed in 20 of these. In 11 patients where biopsies were performed in the presence of inflammation, BE was detected in 2 and missed in 5 (including 2 dysplasias). In 131/169 patients (77.5%), BE was not suspected at index EGD. After healing of EE though, 48 patients had suspicion of BE who underwent biopsies, and in 26 of these histology was positive for BE. The length of inflammation had a linear correlation with the length of BE (P = 0.01). Out of multiple variables to predict BE, only the suspicion at index endoscopy was statistically significant (P = 0.01). Conclusion: BE was seen in 46/169 (27%) patients with EE of LA class B, C and D. The length of EE can predict the length of underlying BE segment. Even when suspected, BE and associated dysplasia can be missed in the presence of inflammation; therefore, repeat evaluation should be considered after complete healing of esophagitis.

Original languageEnglish (US)
Pages (from-to)3518-3522
Number of pages5
JournalWorld Journal of Gastroenterology
Volume14
Issue number22
DOIs
StatePublished - 2008
Externally publishedYes

Fingerprint

Barrett Esophagus
Esophagitis
Duodenoscopy
Inflammation
Los Angeles
Endoscopy
Biopsy
Histology

Keywords

  • Barrett's
  • Erosive esophagitis
  • Gastroesophageal reflux
  • Prevalence of Barrett's

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Prevalence of Barrett's esophagus in patients with moderate to severe erosive esophagitis. / Gilani, Nooman; Gerkin, Richard D.; Ramirez, Francisco C; Hakim, Shahina; Randolph, Adam C.

In: World Journal of Gastroenterology, Vol. 14, No. 22, 2008, p. 3518-3522.

Research output: Contribution to journalArticle

Gilani, Nooman ; Gerkin, Richard D. ; Ramirez, Francisco C ; Hakim, Shahina ; Randolph, Adam C. / Prevalence of Barrett's esophagus in patients with moderate to severe erosive esophagitis. In: World Journal of Gastroenterology. 2008 ; Vol. 14, No. 22. pp. 3518-3522.
@article{d5206c084f91448482b729d271000b2f,
title = "Prevalence of Barrett's esophagus in patients with moderate to severe erosive esophagitis",
abstract = "Aim: To investigate the proportion of patients with moderate-severe erosive esophagitis (EE) who will have Barrett's esophagus (BE) after healing of inflammation. Methods: Patients with EE of Los Angeles (LA) class B, C and D who underwent follow-up endoscopy documenting complete mucosal healing. Results: A total of 86/169 patients were suspected of having BE (38 before healing and 48 after healing of EE) and, 46/86 eventually had the histological confirmation. At index esophago-gastro-duodenoscopy (EGD), BE was suspected in 38/169 (22{\%}), and ultimately, histologically confirmed in 20 of these. In 11 patients where biopsies were performed in the presence of inflammation, BE was detected in 2 and missed in 5 (including 2 dysplasias). In 131/169 patients (77.5{\%}), BE was not suspected at index EGD. After healing of EE though, 48 patients had suspicion of BE who underwent biopsies, and in 26 of these histology was positive for BE. The length of inflammation had a linear correlation with the length of BE (P = 0.01). Out of multiple variables to predict BE, only the suspicion at index endoscopy was statistically significant (P = 0.01). Conclusion: BE was seen in 46/169 (27{\%}) patients with EE of LA class B, C and D. The length of EE can predict the length of underlying BE segment. Even when suspected, BE and associated dysplasia can be missed in the presence of inflammation; therefore, repeat evaluation should be considered after complete healing of esophagitis.",
keywords = "Barrett's, Erosive esophagitis, Gastroesophageal reflux, Prevalence of Barrett's",
author = "Nooman Gilani and Gerkin, {Richard D.} and Ramirez, {Francisco C} and Shahina Hakim and Randolph, {Adam C.}",
year = "2008",
doi = "10.3748/wjg.14.3518",
language = "English (US)",
volume = "14",
pages = "3518--3522",
journal = "World Journal of Gastroenterology",
issn = "1007-9327",
publisher = "WJG Press",
number = "22",

}

TY - JOUR

T1 - Prevalence of Barrett's esophagus in patients with moderate to severe erosive esophagitis

AU - Gilani, Nooman

AU - Gerkin, Richard D.

AU - Ramirez, Francisco C

AU - Hakim, Shahina

AU - Randolph, Adam C.

PY - 2008

Y1 - 2008

N2 - Aim: To investigate the proportion of patients with moderate-severe erosive esophagitis (EE) who will have Barrett's esophagus (BE) after healing of inflammation. Methods: Patients with EE of Los Angeles (LA) class B, C and D who underwent follow-up endoscopy documenting complete mucosal healing. Results: A total of 86/169 patients were suspected of having BE (38 before healing and 48 after healing of EE) and, 46/86 eventually had the histological confirmation. At index esophago-gastro-duodenoscopy (EGD), BE was suspected in 38/169 (22%), and ultimately, histologically confirmed in 20 of these. In 11 patients where biopsies were performed in the presence of inflammation, BE was detected in 2 and missed in 5 (including 2 dysplasias). In 131/169 patients (77.5%), BE was not suspected at index EGD. After healing of EE though, 48 patients had suspicion of BE who underwent biopsies, and in 26 of these histology was positive for BE. The length of inflammation had a linear correlation with the length of BE (P = 0.01). Out of multiple variables to predict BE, only the suspicion at index endoscopy was statistically significant (P = 0.01). Conclusion: BE was seen in 46/169 (27%) patients with EE of LA class B, C and D. The length of EE can predict the length of underlying BE segment. Even when suspected, BE and associated dysplasia can be missed in the presence of inflammation; therefore, repeat evaluation should be considered after complete healing of esophagitis.

AB - Aim: To investigate the proportion of patients with moderate-severe erosive esophagitis (EE) who will have Barrett's esophagus (BE) after healing of inflammation. Methods: Patients with EE of Los Angeles (LA) class B, C and D who underwent follow-up endoscopy documenting complete mucosal healing. Results: A total of 86/169 patients were suspected of having BE (38 before healing and 48 after healing of EE) and, 46/86 eventually had the histological confirmation. At index esophago-gastro-duodenoscopy (EGD), BE was suspected in 38/169 (22%), and ultimately, histologically confirmed in 20 of these. In 11 patients where biopsies were performed in the presence of inflammation, BE was detected in 2 and missed in 5 (including 2 dysplasias). In 131/169 patients (77.5%), BE was not suspected at index EGD. After healing of EE though, 48 patients had suspicion of BE who underwent biopsies, and in 26 of these histology was positive for BE. The length of inflammation had a linear correlation with the length of BE (P = 0.01). Out of multiple variables to predict BE, only the suspicion at index endoscopy was statistically significant (P = 0.01). Conclusion: BE was seen in 46/169 (27%) patients with EE of LA class B, C and D. The length of EE can predict the length of underlying BE segment. Even when suspected, BE and associated dysplasia can be missed in the presence of inflammation; therefore, repeat evaluation should be considered after complete healing of esophagitis.

KW - Barrett's

KW - Erosive esophagitis

KW - Gastroesophageal reflux

KW - Prevalence of Barrett's

UR - http://www.scopus.com/inward/record.url?scp=54349086867&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54349086867&partnerID=8YFLogxK

U2 - 10.3748/wjg.14.3518

DO - 10.3748/wjg.14.3518

M3 - Article

VL - 14

SP - 3518

EP - 3522

JO - World Journal of Gastroenterology

JF - World Journal of Gastroenterology

SN - 1007-9327

IS - 22

ER -